Prevalence and risk factors of retinal vein occlusion: The Gutenberg Health Study

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 7, 2015, Pages 1254-1263

  Ponto, K A ^a   Elbaz, H ^a,b,c   Peto, T ^b   Laubert Reh, D ^a   Binder, H ^a   Wild, P S ^a,d   Lackner, K ^a   Pfeiffer, N ^a   Mirshahi, A ^a,e  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^e Dardenne Eye Hospital Bonn Bad Godesberg   (Germany)

Author keywords

Population; Prevalence; Retinal disease; Retinal vein occlusion; Risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATRIAL FIBRILLATION; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE FUNDUS; EYE PHOTOGRAPHY; FAMILY HISTORY; FEMALE; GERMANY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VISUAL ACUITY; AGE; ODDS RATIO; PATHOPHYSIOLOGY; PHENOTYPE; RETINAL VEIN OCCLUSION; STATISTICAL MODEL; STROKE; VISION DISORDERS;

ADULT; AGE FACTORS; AGED; ATRIAL FIBRILLATION; FEMALE; GERMANY; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PREVALENCE; RETINAL VEIN OCCLUSION; RISK FACTORS; SEX FACTORS; STROKE; VISION DISORDERS; VISUAL ACUITY;

EID: 84935728251     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12982     Document Type: Article

References (65)

1. Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event. Surv Ophthalmol 2011; 56: 281-99.
2. Suner IJ, Margolis J, Ruiz K, Tran I, Lee P. Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and medicare populations. Retina 2014; 34: 2250-8.
3. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010; 8: 1886-94.
4. Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999; 106: 2054-62.
5. McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen HP, Wong TY. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010; 117: e15.
6. Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, Nguyen HP, Wang JJ, Wong TY. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010; 117: e5.
7. Laouri M, Chen E, Looman M, Gallagher M. The burden of disease of retinal vein occlusion: review of the literature.Eye (Lond) 2011; 25: 981-8.
8. Bertelsen M, Linneberg A, Christoffersen N, Vorum H, Gade E, Larsen M. Mortality in patients with central retinal vein occlusion. Ophthalmology 2014; 121: 637-42.
9. Kuhli C, Hattenbach LO, Scharrer I, Koch F, Ohrloff C. High prevalence of resistance to APC in young patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 163-8.
10. Kuhli C, Jochmans K, Scharrer I, Luchtenberg M, Hattenbach LO. Retinal vein occlusion associated with antithrombin deficiency secondary to a novel G9840C missense mutation. Arch Ophthalmol 2006; 124: 1165-9.
11. Kuhli C, Scharrer I, Koch F, Ohrloff C, Hattenbach LO. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthalmol 2004; 137: 459-64.
12. Kuhli-Hattenbach C, Scharrer I, Luchtenberg M, Hattenbach LO. Coagulation disorders and the risk of retinal vein occlusion. Thromb Haemost 2010; 103: 299-305.
13. Lip PL, Blann AD, Jones AF, Lip GY. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye (Lond) 1998; 12: 245-51.
14. Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol 2014; 2014: 724780.
15. Risk factors for branch retinal vein occlusion. The eye disease case-control study group. Am J Ophthalmol 1993; 116: 286-96.
16. Risk factors for central retinal vein occlusion. The eye disease case-control study group. Arch Ophthalmol 1996; 114: 545-54.
17. Mirshahi A, Ponto KA, Hohn R, Wild PS, Pfeiffer N. Ophthalmological aspects of the Gutenberg Health Study (GHS): an interdisciplinary prospective population-based cohort study. Ophthalmologe 2013; 110: 210-7.
18. Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, Pfeiffer N, Munzel T, Blankenberg S. The gutenberg health study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012; 55: 824-9.
19. Hoffmann EM, Lamparter J, Mirshahi A, Elflein H, Hoehn R, Wolfram C, Lorenz K, Adler M, Wild PS, Schulz A, Mathes B, Blettner M, Pfeiffer N. Distribution of central corneal thickness and its association with ocular parameters in a large central European cohort: the Gutenberg health study. PLoS One 2013; 8: e66158.
20. Korb CA, Kottler UB, Wolfram C, Hoehn R, Schulz A, Zwiener I, Wild PS, Pfeiffer N, Mirshahi A. Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 2014; 252: 1403-11.
21. Lamparter J, Raum P, Pfeiffer N, Peto T, Hohn R, Elflein H, Wild P, Schulz A, Schneider A, Mirshahi A. Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study. J Diabetes Complications 2014; 28: 482-7.
22. Mirshahi A, Ponto KA, Hoehn R, Zwiener I, Zeller T, Lackner K, Beutel ME, Pfeiffer N. Myopia and level of education: results from the gutenberg health study. Ophthalmology 2014; 121: 2047-52.
23. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114: 1243-7.
24. Liu W, Xu L, Jonas JB. Vein occlusion in Chinese subjects. Ophthalmology 2007; 114: 1795-6.
25. Yasuda M, Kiyohara Y, Arakawa S, Hata Y. Yonemoto K, Doi Y, Iida M, Ishibashi T. Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 2010; 51: 3205-9.
26. Lim LL, Cheung N, Wang JJ, Islam FM, Mitchell P, Saw SM, Aung T, Wong TY. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol 2008; 92: 1316-9.
27. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000; 98: 133-41.
28. Cheung N, Klein R, Wang JJ, Cotch MF, Islam AF, Klein BE, Cushman M, Wong TY. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci 2008; 49: 4297-302.
29. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010; 117: 313-9. e1.
30. Bertelsen M, Linneberg A, Rosenberg T, Christoffersen N, Vorum H, Gade E, Larsen M. Comorbidity in patients with branch retinal vein occlusion: case-control study. BMJ 2012; 345: e7885.
31. Christoffersen N, Gade E, Knudsen L, Juel K, Larsen M. Mortality in patients with branch retinal vein occlusion. Ophthalmology 2007; 114: 1186-9.
32. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001; 131: 61-77.
33. Lee JY, Yoon YH, Kim HK, Yoon HS, Kang SW, Kim JG, Park KH, Jo YJ. Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group. J Korean Med Sci 2013; 28: 136-44.
34. Martin SC, Butcher A, Martin N, Farmer J, Dobson PM, Bartlett WA, Jones AF. Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 2002; 86: 774-6.
35. Newman-Casey PA, Stem M, Talwar N, Musch DC, Besirli CG, Stein JD. Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan. Ophthalmology 2014; 121: 1939-48.
36. Johnston RL, Brucker AJ, Steinmann W, Hoffman ME, Holmes JH. Risk factors of branch retinal vein occlusion. Arch Ophthalmol 1985; 103: 1831-2.
37. O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008; 126: 692-9.
38. Jonas JB, Nangia V, Khare A, Sinha A, Lambat S. Prevalence and associations of retinal vein occlusions: the Central India Eye and Medical Study. Retina 2013; 33: 152-9.
39. Werther W, Chu L, Holekamp N, Do DV, Rubio RG. Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusion. Arch Ophthalmol 2011; 129: 326-31.
40. Christiansen CB, Lip GY, Lamberts M, Gislason G, Torp-Pedersen C, Olesen JB. Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. J Thromb Haemost 2013; 11: 1485-92.
41. Kittisupamongkol W. Atrial fibrillation in patients diagnosed with retinal vein occlusion. Am J Ophthalmol 2009; 147: 1104; author reply - 5.
42. Plunkett O, Lip PL, Lip GY. Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye. Br J Ophthalmol 2014; 98: 1141-3.
43. Prandoni P. Venous thromboembolism and atherosclerosis: is there a link? J Thromb Haemost 2007; 5 (Suppl. 1): 270-5.
44. Hayreh SS, Podhajsky PA, Zimmerman MB. Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants. Ophthalmology 2011; 118: 1603-11.
45. Sartori MT, Barbar S, Dona A, Piermarocchi S, Pilotto E, Saggiorato G, Prandoni P. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study. Eur J Haematol 2013; 90: 426-33.
46. Barathi VA, Yeo SW, Guymer RH, Wong TY, Luu CD. Effects of simvastatin on retinal structure and function of a high-fat atherogenic mouse model of thickened Bruch's membrane. Invest Ophthalmol Vis Sci 2014; 55: 460-8.
47. Ko ML, Chen CF, Peng PH, Peng YH. Simvastatin upregulates Bcl-2 expression and protects retinal neurons from early ischemia/reperfusion injury in the rat retina. Exp Eye Res 2011; 93: 580-5.
48. Krempler K, Schmeer CW, Isenmann S, Witte OW, Lowel S. Simvastatin improves retinal ganglion cell survival and spatial vision after acute retinal ischemia/reperfusion in mice. Invest Ophthalmol Vis Sci 2011; 52: 2606-18.
49. Medina RJ, O'Neill CL, Devine AB, Gardiner TA, Stitt AW. The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies. PLoS One 2008; 3: e2584.
50. Terai N, Spoerl E, Fischer S, Hornykewycz K, Haustein M, Haentzschel J, Pillunat LE. Statins affect ocular microcirculation in patients with hypercholesterolaemia. Acta Ophthalmol 2011; 89: e500-4.
51. Sanborn GE, Magargal LE. Characteristics of the hemispheric retinal vein occlusion. Ophthalmology 1984; 91: 1616-26.
52. Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology 1998; 105: 765-71.
53. Appiah AP, Trempe CL. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions. Ophthalmology 1989; 96: 364-6.
54. Azar G, Voigt M, Al-Arabi Z, Lachkar Y. Primary open-angle glaucoma (POAG), retinal vein occlusions (RVO) and central corneal thickness (CCT): what is the relationship? J Fr Ophtalmol 2013; 36: 449-54.
55. Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO. The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology 2010; 117: 484-8.
56. Beaumont PE, Kang HK. Cup-to-disc ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusion. Ophthalmology 2002; 109: 282-6.
57. David R, Zangwill L, Badarna M, Yassur Y. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 1988; 197: 69-74.
58. Hirota A, Mishima HK, Kiuchi Y. Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University. Ophthalmologica 1997; 211: 288-91.
59. Prata TS, Rozenbaum I, de Moraes CG, Lima VC, Liebmann J, Ritch R. Retinal vascular occlusions occur more frequently in the more affected eye in exfoliation syndrome. Eye (Lond) 2010; 24: 658-62.
60. Klein BE, Meuer SM, Knudtson MD, Klein R. The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study. Am J Ophthalmol 2006; 141: 859-62.
61. Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126: 513-8.
62. Bandello F, Tavola A, Pierro L, Modorati G, Azzolini C, Brancato R. Axial length and refraction in retinal vein occlusions. Ophthalmologica 1998; 212: 133-5.
63. Simons BD, Brucker AJ. Branch retinal vein occlusion. Axial length and other risk factors. Retina 1997; 17: 191-5.
64. Timmerman EA, de Lavalette VW, van den Brom HJ. Axial length as a risk factor to branch retinal vein occlusion. Retina 1997; 17: 196-9.
65. Kir E, Tulin Berk A, Osman Saatci A, Kaynak S, Ergin MHAxial length and hyperopia in eyes with retinal vein occlusions. Int Ophthalmol 1997; 21: 209-11.